Chunyan Song

Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study

Josep Tabernero, Paulo M. Hoff, Lin Shen et al. · The Lancet Oncology · 2018 · 468 citations

Surgical Oncology, Her2-positive Metastatic Gastric, Placebo-controlled Phase 3 +8

Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Sara A. Hurvitz, Luc Dirix, Judit Kocsis et al. · Journal of Clinical Oncology · 2013 · 389 citations

Machine learning based early warning system enables accurate mortality risk prediction for COVID-19

Yue Gao, Guangyao Cai, Wei Fang et al. · Nature Communications · 2020 · 349 citations · Full text

Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study

Sara A. Hurvitz, Miguel Martín, Kyung Hae Jung et al. · Journal of Clinical Oncology · 2019 · 238 citations · Full text

Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast Cancer

Nicholas C. Turner, Seock‐Ah Im, Cristina Saura et al. · New England Journal of Medicine · 2024 · 178 citations